Literature DB >> 11415994

Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity.

S C Ho1, J Van Sande, A Lefort, G Vassart, S Costagliola.   

Abstract

A model has been proposed in which, in the absence of TSH, the extracellular domain of the TSH receptor would exert a silencing effect on the serpentine domain involved in activation of the G(alpha)(s) protein. Mutation of S281 in the ectodomain is supposed to release this constraint, thereby causing receptor activation. This defines S281 and its neighbors as a segment important in intramolecular signal transduction. The functional importance of this segment was explored by site-directed mutagenesis experiments involving S281, as well as the two cysteine residues (C283, C284) present immediately downstream. S281 was mutated to N, T, G, and A in this study, and the functional characteristics of the mutants were compared. We found that S281N, S281T, and S281G display stronger constitutive activity than S281A mutant, suggesting that increase in constitutive activity is related to the extent of disruption of the local structure of the ectodomain. C283 and C284, the two consecutive cysteines that are highly conserved in glycoprotein hormone receptors, were mutated to serine, either alone (S281HSC or S281HCS) or in combination (S281HSS) and were studied in two different TSH receptor backgrounds. The mutated cysteine ectodomains were either linked to a glycosylphosphatidylinositol anchor or the serpentine domain of the wild-type holoreceptor. Glycosylphosphatidylinositol-anchored ectodomain receptors showed good cell surface expression in CHO cells, but only S281HCS was able to bind TSH specifically, illustrating the importance of C283, or the putative disulphide bond, in maintaining the conformation of the ligand binding site. In contrast, cysteine mutants on an extracellular domain-holoreceptor background displayed severely impaired membrane targeting and were poorly expressed in COS cells. However, basal cAMP production, normalized to expression at the plasma membrane, indicated significant increase in constitutive activity of all three mutants, compared with the wild-type receptor. Altogether, these findings support a model in which the ectodomain would act as a silencer of the basal activity of the serpentine portion of the receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11415994     DOI: 10.1210/endo.142.7.8246

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases.

Authors:  Antje Brüser; Angela Schulz; Sven Rothemund; Albert Ricken; Davide Calebiro; Gunnar Kleinau; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

Review 2.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

3.  The antibodies against the computationally designed mimic of the glycoprotein hormone receptor transmembrane domain provide insights into receptor activation and suppress the constitutively activated receptor mutants.

Authors:  Ritankar Majumdar; Reema Railkar; Rajan R Dighe
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

4.  Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

Authors:  S Costagliola; V Panneels; M Bonomi; J Koch; M C Many; G Smits; G Vassart
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

5.  Research resource: novel structural insights bridge gaps in glycoprotein hormone receptor analyses.

Authors:  Annika Kreuchwig; Gunnar Kleinau; Gerd Krause
Journal:  Mol Endocrinol       Date:  2013-06-24

6.  Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.

Authors:  E Nishihara; C-R Chen; Y Mizutori-Sasai; M Ito; S Kubota; N Amino; A Miyauchi; B Rapoport
Journal:  J Endocrinol Invest       Date:  2011-05-19       Impact factor: 4.256

7.  Defining structural and functional dimensions of the extracellular thyrotropin receptor region.

Authors:  Gunnar Kleinau; Sandra Mueller; Holger Jaeschke; Paul Grzesik; Susanne Neumann; Anne Diehl; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

8.  Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor.

Authors:  Gunnar Kleinau; Holger Jaeschke; Sandra Mueller; Bruce M Raaka; Susanne Neumann; Ralf Paschke; Gerd Krause
Journal:  FASEB J       Date:  2008-04-01       Impact factor: 5.191

9.  Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism.

Authors:  J Lueblinghoff; S Mueller; J Sontheimer; R Paschke
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

Review 10.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.